| Literature DB >> 34789304 |
Youn-Jung Kim1, Min-Jee Kim2, Yong Hwan Kim3, Chun Song Youn4, In Soo Cho5, Su Jin Kim6, Jung Hee Wee7, Yoo Seok Park8, Joo Suk Oh9, Dong Hoon Lee10, Won Young Kim11.
Abstract
BACKGROUND: We assessed the prognostic accuracy of the standardized electroencephalography (EEG) patterns ("highly malignant," "malignant," and "benign") according to the EEG timing (early vs. late) and investigated the EEG features to enhance the predictive power for poor neurologic outcome at 1 month after cardiac arrest.Entities:
Keywords: Electroencephalography; Neurologic outcome; Out-of-hospital cardiac arrest; Prognosis; Targeted temperature management
Mesh:
Year: 2021 PMID: 34789304 PMCID: PMC8596386 DOI: 10.1186/s13054-021-03823-y
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 9.097
Fig. 1Flow diagram of the patient selection process. CPC, cerebral performance category; EEG, electroencephalography; OHCA, out-of-hospital cardiac arrest; ROSC, return of spontaneous circulation; TTM, targeted temperature management
Demographic and clinical characteristics of the study patients according to electroencephalography timing
| Characteristics | Total ( | Patients with EEG < 72 h | Patients with EEG of 72 h to 7 days ( | |
|---|---|---|---|---|
| Age, years | 58.0 (46.0–69.0) | 58.0 (46.0–69.0) | 57.0 (46.3–67.0) | 0.515 |
| Male | 341 (69.7%) | 251 (71.1%) | 90 (66.2%) | 0.288 |
| Previous medical history | ||||
| Hypertension | 171 (35.0%) | 127 (36.0%) | 44 (32.4%) | 0.451 |
| Diabetes mellitus | 99 (20.2%) | 78 (22.1%) | 21 (15.4%) | 0.101 |
| Acute myocardial infarction | 25 (5.1%) | 16 (4.5%) | 9 (6.6%) | 0.348 |
| Congestive heart failure | 18 (3.7%) | 13 (3.7%) | 5 (3.7%) | 0.997 |
| Chronic kidney disease | 38 (7.8%) | 30 (8.5%) | 8 (5.9%) | 0.333 |
| Cardiac arrest characteristics | ||||
| Witnessed | 313 (64.0%) | 228 (64.6%) | 85 (62.5%) | 0.666 |
| Bystander CPR | 296 (60.5%) | 212 (60.1%) | 84 (61.8%) | 0.729 |
| Initial shockable rhythm | 169 (34.6%) | 127 (36.0%) | 42 (30.9%) | 0.288 |
| No flow time, min | 1.0 (0.0–6.0) | 1.0 (0.0–6.0) | 1.0 (0.0–7.0) | 0.935 |
| Resuscitation duration, min | 24.0 (13.5–36.0) | 24.0 (13.0–37.5) | 24.0 (14.0–32.0) | 0.48 |
| Time from ROSC to TTM initiation, hours | 3.2 (2.0–4.7) | 3.2 (1.9–4.6) | 3.3 (2.2–4.7) | 0.599 |
| Target temperature | 0.049 | |||
| 33 °C | 273 (55.8%) | 185 (52.4%) | 88 (64.7%) | |
| 34–35 °C | 160 (32.7%) | 124 (35.1%) | 36 (26.5%) | |
| 36 °C | 56 (11.5%) | 44 (12.5%) | 12 (8.8%) | |
| Time from ROSC to EEG examination, hours | 46.6 (23.9–73.9) | 31.5 (20.0–52.0) | 90.8 (77.8–106.1) | < 0.001 |
| Poor neurological outcome at 1 month | 341 (69.7%) | 243 (68.8%) | 98 (72.1%) | 0.487 |
| Death at 1 month | 231 (47.2%) | 166 (47.0%) | 65 (47.8%) | 0.879 |
| Poor neurological outcome at 6 months | 335 (69.4%), | 237 (68.3%), | 98 (72.1%), | 0.420 |
| Death at 6 months | 276 (57.1%), | 197 (56.8%), | 79 (58.1%), | 0.793 |
Values are expressed as median (interquartile range) or n (%) as appropriate
CPR, cardiopulmonary resuscitation; ROSC, return of spontaneous circulation; TTM, targeted temperature management; EEG, electroencephalography
Electroencephalography patterns and findings of the study patients according to electroencephalography timing
| EEG findings | Total ( | Patients with EEG < 72 h | Patients with EEG of 72 h to 7 days | |
|---|---|---|---|---|
| EEG background frequency | 0.220 | |||
| Predominant alpha waves | 106 (21.7%) | 84 (23.8%) | 22 (16.2%) | |
| Predominant theta waves | 127 (26.0%) | 87 (24.6%) | 40 (29.4%) | |
| Predominant delta waves | 90 (18.4%) | 67 (19.0%) | 23 (16.9%) | |
| Undetermined | 166 (33.9%) | 115 (32.6%) | 51 (37.5%) | |
| Categorization | 0.934 | |||
| Highly malignant pattern | 199 (40.7%) | 144 (40.8%) | 55 (40.4%) | |
| Malignant pattern | 124 (25.4%) | 88 (24.9%) | 36 (26.5%) | |
| Benign | 166 (33.9%) | 121 (34.3%) | 45 (33.1%) | |
| Highly malignant pattern | ||||
| Suppressed background without discharges | 154 (31.5%) | 106 (30.0%) | 48 (35.3%) | 0.261 |
| Suppressed background with continuous periodic discharges | 10 (2.0%) | 8 (2.3%) | 2 (1.5%) | 0.733 |
| Burst-suppression | 35 (7.2%) | 30 (8.5%) | 5 (3.7%) | 0.064 |
| Malignant rhythmic or periodic features | 67 (13.7%) | 44 (12.5%) | 23 (16.9%) | 0.2 |
| Periodic discharges (≥ 50%) | 30 (6.1%) | 19 (5.4%) | 11 (8.1%) | 0.264 |
| Rhythmic spike-and-wave (≥ 50%) | 28 (5.7%) | 21 (5.9%) | 7 (5.1%) | 0.732 |
| Unequivocal seizures or status epilepticus | 53 (10.8%) | 37 (10.5%) | 16 (11.8%) | 0.683 |
| Malignant background | 85 (17.4%) | 64 (18.1%) | 21 (15.4%) | 0.527 |
| Discontinuous (> 10% suppression) | 16 (3.3%) | 10 (2.8%) | 6 (4.4%) | 0.399 |
| Low voltage (< 20 μV) | 61 (12.5%) | 47 (13.3%) | 14 (10.3%) | 0.365 |
| Reversed anteroposterior gradient | 14 (2.9%) | 11 (3.1%) | 3 (2.2%) | 0.766 |
Values are expressed as number (%)
EEG, electroencephalography
Electroencephalography findings and clinical examinations of the study patients in the early and late electroencephalography groups according to neurologic outcome at 1 month
| EEG findings and clinical neurological examinations | Patients with EEG < 72 h | Patients with EEG of 72 h to 7 days | ||||
|---|---|---|---|---|---|---|
| Good neurologic outcome | Poor neurologic outcome | Good neurologic outcome | Poor neurologic outcome | |||
| EEG background frequency | < 0.001 | < 0.001 | ||||
| Dominant alpha waves | 69 (62.7%) | 15 (6.2%) | 14 (36.8%) | 8 (8.2%) | ||
| Dominant theta waves | 36 (32.7%) | 51 (21.0%) | 20 (52.6%) | 20 (20.4%) | ||
| Dominant delta waves | 5 (4.5%) | 62 (25.5%) | 4 (10.5%) | 19 (19.4%) | ||
| Undetermined | 0 (0%) | 115 (47.3%) | 0 (0%) | 51 (52.0%) | ||
| Categorization | < 0.001 | < 0.001 | ||||
| Highly malignant pattern | 0 (0%) | 144 (59.3%) | 0 (0%) | 55 (56.1%) | ||
| Malignant pattern | 24 (21.8%) | 64 (26.3%) | 10 (26.3%) | 26 (26.5%) | ||
| Benign | 86 (78.2%) | 35 (14.4%) | 28 (73.7%) | 17 (17.3%) | ||
| 0 (0%) | 144 (59.3%) | < 0.001 | 0 (0%) | 55 (56.1%) | < 0.001 | |
| Suppressed background without discharges | 0 (0%) | 106 (43.6%) | < 0.001 | 0 (0%) | 48 (49.0%) | < 0.001 |
| Suppressed background with continuous periodic discharges | 0 (0%) | 8 (3.3%) | 0.061 | 0 (0%) | 2 (2.0%) | > 0.999 |
| Burst-suppression | 0 (0%) | 30 (12.3%) | < 0.001 | 0 (0%) | 5 (5.1%) | 0.322 |
| 6 (5.5%) | 38 (15.6%) | 0.007 | 7 (18.4%) | 16 (16.3%) | 0.770 | |
| Periodic discharges (≥ 50%) | 2 (1.8%) | 17 (7.0%) | 0.046 | 3 (7.9%) | 8 (8.2%) | > 0.999 |
| Rhythmic spike-and-wave (≥ 50%) | 3 (2.7%) | 18 (7.4%) | 0.085 | 1 (2.6%) | 6 (6.1%) | 0.673 |
| Unequivocal seizures or status epilepticus | 3 (2.7%) | 34 (14.0%) | 0.001 | 6 (15.8%) | 10 (10.2%) | 0.382 |
| 18 (16.4%) | 46 (18.9%) | 0.562 | 3 (7.9%) | 18 (18.4%) | 0.129 | |
| Discontinuous (> 10% suppression) | 2 (1.8%) | 8 (3.3%) | 0.730 | 1 (2.6%) | 5 (5.1%) | > 0.999 |
| Low voltage (< 20 μV) | 14 (12.7%) | 33 (13.6%) | 0.827 | 2 (5.3%) | 12 (12.2%) | 0.349 |
| Reversed anteroposterior gradient | 2 (1.8%) | 9 (3.7%) | 0.513 | 0 (0%) | 3 (3.1%) | 0.560 |
| Absent pupillary reflex at ≥ 72 h after ROSCa | 5 (4.7%), | 158 (67.8%), | < 0.001 | 2 (5.3%), | 62 (63.9%), | < 0.001 |
| Absent corneal reflex at ≥ 72 h after ROSCa | 16 (20.3%), | 170 (85.9%), | < 0.001 | 5 (16.1%), | 59 (79.7%), | < 0.001 |
| Motor component of the Glasgow Coma Scoreb | ||||||
| ≤ 3 at 48 h after ROSC | 83 (77.6%), | 238 (98.8%), | < 0.001 | 28 (77.8%), | 96 (99.0%), | < 0.001 |
| ≤ 3 at 72 h after ROSC | 55 (50.5%), | 233 (97.9%), | < 0.001 | 16 (45.7%), | 96 (98.0%), | < 0.001 |
Values are expressed as number (%)
EEG, electroencephalography; ROSC, return of spontaneous circulation
aA total of 13 patients dead < 72 h after ROSC were categorized as absent ocular reflexes
bTwo patients dead < 48 h after ROSC were categorized as motor component ≤ 3. Similarly, 13 patients dead < 72 h were categorized as motor component ≤ 3
Predictive value of “highly malignant” and “malignant” electroencephalography patterns and dominant electroencephalography frequency for poor neurologic outcome at 1 month
| Variables | EEG timing | True positive | False positive | True negative | False negative | Sensitivity (95% CI) | Specificity (95% CI) | PPV (95% CI) | NPV (95% CI) | Accuracy (95% CI) |
|---|---|---|---|---|---|---|---|---|---|---|
| Highly malignant pattern | < 72 h | 144 | 0 | 110 | 99 | 59.3 (52.8–65.5) | 100.0 (96.7–100.0) | 100 | 52.6 (48.8–56.4) | 72.0 (67.0–76.6) |
| Between 72 h and 7 days | 55 | 0 | 38 | 43 | 56.1 (45.7–66.1) | 100.0 (90.8–100.0) | 100 | 46.9 (41.4–52.5) | 68.4 (59.9–76.1) | |
| < 7 days | 199 | 0 | 148 | 142 | 58.4 (52.9–63.6) | 100.0 (97.5–100.0) | 100 | 51.0 (47.9–54.2) | 71.0 (66.7–75.0) | |
| Highly malignant or malignant patterns | < 72 h | 208 | 24 | 86 | 35 | 85.6 (80.5–89.8) | 78.2 (69.3–85.5) | 89.7 (85.8–92.5) | 71.1 (64.0–77.2) | 83.3 (79.0–87.0) |
| Between 72 h and 7 days | 81 | 17 | 28 | 10 | 82.7 (73.7–89.6) | 73.7 (56.9–86.6) | 89.0 (82.5–93.3) | 62.2 (50.7–72.5) | 80.2 (72.5–86.5) | |
| < 7 days | 289 | 34 | 114 | 52 | 84.8 (80.5–88.4) | 77.0 (69.4–83.5) | 89.5 (86.3–92.0) | 68.7 (62.7–74.1) | 82.4 (78.7–85.7) | |
| Highly malignant or malignant patterns with delta or undetermined frequency | < 72 h | 171 | 2 | 108 | 72 | 70.4 (64.2–76.0) | 98.2 (93.6–99.8) | 98.8 (95.6–99.7) | 60.0 (55.2–64.6) | 79.0 (74.4–83.2) |
| Between 72 h and 7 days | 65 | 1 | 37 | 33 | 66.3 (56.1–75.6) | 97.4 (86.2–99.9) | 98.5 (90.3–99.8) | 52.9 (45.8–59.8) | 75.7 (67.9–82.0) | |
| < 7 days | 236 | 3 | 145 | 105 | 69.2 (64.0–74.1) | 98.0 (94.2–99.6) | 98.7 (96.2–99.6) | 58.0 (54.0–61.9) | 77.9 (74.0–81.5) |
CI, confidence interval; EEG, electroencephalography; NPV, negative predictive value; PPV, positive predictive value
The distribution of cerebral performance category score at 1 month and the cause of death
| Variable | Total ( | Highly malignant or malignant patterns with delta or undetermined frequency | |
|---|---|---|---|
| Yes ( | No ( | ||
| CPC 1 | 134 (27.4%) | 2 (0.8%) | 132 (52.8%) |
| CPC 2 | 14 (2.9%) | 1 (0.4%) | 13 (5.2%) |
| CPC 3 | 19 (3.9%) | 4 (1.7%) | 15 (6.0%) |
| CPC 4 | 91 (18.6%) | 53 (22.2%) | 38 (15.2%) |
| CPC 5 | 231 (47.2%) | 179 (74.9%) | 52 (20.8%) |
| Cause of death | |||
| Cerebral cause | 108 (46.8%) | 92 (51.4%) | 16 (30.8%) |
| Multiple organ failure | 68 (29.4%) | 47 (26.3%) | 21 (40.4%) |
| Cardiovascular cause | 25 (10.8%) | 17 (9.5%) | 8 (15.4%) |
| Others/ Unknown | 30 (13.0%) | 23 (12.8%) | 7 (13.5%) |
| Death after awakeninga | 6 (2.6%) | 0 (0%) | 6 (11.5%) |
| Withholding therapies | 52 (10.6%) | 42 (17.6%) | 10 (4.0%) |
| No therapeutic escalation | 9 (1.8%) | 8 (3.3%) | 1 (0.4%) |
| No cardiopulmonary resuscitation | 41 (8.4%) | 32 (13.4%) | 9 (3.6%) |
| Time to withholding of active treatment, hours | 82.0 (40.3–118.3) | 89.5 (39.5–125.0) | 78.0 (35.8–97.0) |
Values are expressed as number (%) and median (interquartile range)
CPC, cerebral performance category
aA total of 6 patients were dead after awakening due to cardiovascular cause (n = 2), multiple organ failure (n = 1) and others/unknown cause (n = 3)